Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) EBT Margin Growth (3y) (2022 - 2025)

Analysis

Evotec SE (EVO) EBT Margin Growth (3y) (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn -317.00
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 501.00
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn -684.00
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn -173.00
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn -522.00
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn -6,872.00
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn 1,586.00
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn 4,862.00
10 VivoSim Labs 1.47 Mn 1.47 Mn - -981,044.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.97 Mn
Sep 30, 2025 -5,115.00
Jun 30, 2025 -209.00
Mar 31, 2025 4.17 Mn
Dec 31, 2024 -4.72 Mn
Sep 30, 2024 -8.80 Mn
Jun 30, 2024 -4.33 Mn
Mar 31, 2024 -4.09 Mn
Dec 31, 2023 -414,273.00
Dec 31, 2022 -5.69 Mn